Life ScienceCompany
Neovasc - XenoSure Rights Ownership
Who owns Neovasc - XenoSure Rights?
Neovasc - XenoSure Rights is owned by LeMaitre Vascular. It was acquired on October 1, 2012.
Neovasc - XenoSure Rights Business Overview
Where is Neovasc - XenoSure Rights headquartered?
Neovasc - XenoSure Rights is headquartered in United States.
What sector is Neovasc - XenoSure Rights in?
Neovasc - XenoSure Rights is a life science company.
Life Science M&A Summary in 2012
Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.
Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.